Your browser doesn't support javascript.
loading
Remifentanil Protects against Lipopolysaccharide-Induced Inflammation through PARP-1/NF-κB Signaling Pathway.
Zhang, Jian-Ning; Ma, Yang; Wei, Xi-Yan; Liu, Ke-Yin; Wang, Hao; Han, Hui; Cui, Yi; Zhang, Ming-Xiang; Qin, Wei-Dong.
Afiliación
  • Zhang JN; Department of Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • Ma Y; Department of Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • Wei XY; Department of Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • Liu KY; State Key Laboratory of Biobased Material and Green Papermaking, Key Laboratory of Pulp & Paper Science and Technology of Shandong Province/Ministry of Education, Qilu University of Technology, Shandong Academy of Sciences, Jinan, China.
  • Wang H; Department of Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • Han H; Department of Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • Cui Y; Department of Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • Zhang MX; The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health, Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • Qin WD; Department of Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Mediators Inflamm ; 2019: 3013716, 2019.
Article en En | MEDLINE | ID: mdl-32082073

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Lipopolisacáridos / FN-kappa B / Poli(ADP-Ribosa) Polimerasa-1 / Remifentanilo / Inflamación Límite: Humans Idioma: En Revista: Mediators Inflamm Asunto de la revista: BIOQUIMICA / PATOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Lipopolisacáridos / FN-kappa B / Poli(ADP-Ribosa) Polimerasa-1 / Remifentanilo / Inflamación Límite: Humans Idioma: En Revista: Mediators Inflamm Asunto de la revista: BIOQUIMICA / PATOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: China